Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company... Show more
The Moving Average Convergence Divergence (MACD) for KSPHF turned positive on November 07, 2025. Looking at past instances where KSPHF's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 16 cases where KSPHF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 03, 2025. You may want to consider a long position or call options on KSPHF as a result. In of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
KSPHF moved above its 50-day moving average on November 26, 2025 date and that indicates a change from a downward trend to an upward trend.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.976) is normal, around the industry mean (17.312). P/E Ratio (14.533) is within average values for comparable stocks, (72.847). KSPHF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). Dividend Yield (0.024) settles around the average of (0.030) among similar stocks. P/S Ratio (2.298) is also within normal values, averaging (55.504).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KSPHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsGeneric
A.I.dvisor tells us that KSPHF and LVRLF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KSPHF and LVRLF's prices will move in lockstep.
| Ticker / NAME | Correlation To KSPHF | 1D Price Change % | ||
|---|---|---|---|---|
| KSPHF | 100% | N/A | ||
| LVRLF - KSPHF | 5% Poorly correlated | N/A | ||
| INDV - KSPHF | 1% Poorly correlated | +1.19% | ||
| MILFF - KSPHF | 1% Poorly correlated | N/A | ||
| HSTI - KSPHF | 1% Poorly correlated | N/A | ||
| HTSUF - KSPHF | 0% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To KSPHF | 1D Price Change % |
|---|---|---|
| KSPHF | 100% | N/A |
| Pharmaceuticals: Generic industry (213 stocks) | 4% Poorly correlated | +0.76% |